How Recent Developments Are Rewriting the Story for Lifecore Biomedical

Lifecore Biomedical’s stock narrative remains in focus as the consensus analyst price target stays unchanged at $8.75. This reflects steady expectations despite evolving market conditions. Shifts in revenue growth projections and a modest…